Measures to help breast cancer patients avoid premature menopause

Australian researchers announced on May 31 that a new approach could help breast cancer patients avoid the risk of early menopause.

After conducting research on 218 women in many parts of the world, experts from the Peter MacCallum Cancer Center in Melbourne found regular monthly goserelin injections to reduce temporary menopause. time

Photo: urmericforhealth.com

Patients who use goserelin regularly during chemotherapy reduce their risk of early menopause by 64%. The likelihood of these people still able to give birth after cancer treatment has nearly doubled compared to those who do not use goserelin.

Experts say this is an important finding for breast cancer patients, especially young patients. According to statistics, about 800 women in Australia have breast cancer less than 40 years old.

In recent years, breast cancer is considered one of the most common cancers in women, especially those who are premenopausal or menopausal.

It is also the disease that causes the highest risk of death among cancers. It is estimated that there are about 12 million cases of cancer every year in the world, including 1.4 million cases of breast cancer.

The World Health Organization has warned that if it does not timely improve preventive measures, early diagnosis and appropriate lifestyle changes, the world will have 19 million women with breast cancer by 2025. .